EV/EBITDA
-7.35
+0.16+2.13%
5 min ago
Summary
- As of February 7, 2025, YMAB EV/EBITDA is -7.35, with a rise of +0.16 (+2.13%) during the most recent trading day.
- Over the past year, YMAB EV/EBITDA has increased by +12.32 (+62.63%).
- YMAB EV/EBITDA is now -5150.00% below its all-time high of -0.14.
Performance
YMAB EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
YMAB EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +2.1% | -2.1% | -1.6% |
| 1 m1 month | +25.7% | -25.7% | -20.6% |
| 3 m3 months | +67.5% | -67.5% | -61.0% |
| 6 m6 months | +52.0% | -50.5% | -44.8% |
| ytdytd | +29.7% | -29.7% | -24.1% |
| 1 y1 year | +62.6% | -58.2% | -53.3% |
| 5 y5 years | +44.7% | -81.4% | -81.5% |
YMAB EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -2.2% | -10.32 | +28.8% | |
| 3 m | 3-month | -7.19 | -2.2% | -22.81 | +67.8% |
| 6 m | 6-month | -7.19 | -2.2% | -22.81 | +67.8% |
| 1 y | 1-year | -7.19 | -2.2% | -33.59 | +78.1% |
| 3 y | 3-year | -0.14 | -5150.0% | -33.59 | +78.1% |
| 5 y | 5-year | -0.14 | -5150.0% | -33.92 | +78.3% |
| alltime | all time | -0.14 | -5150.0% | -33.92 | +78.3% |
Y-mAbs Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -7.35(-29.7%) |
| 2024 | -10.45(+18.3%) |
| 2023 | -8.83(+661.2%) |
| 2022 | -1.16(-88.5%) |
| Date | Value |
|---|---|
| 2021 | -10.08(-36.7%) |
| 2020 | -15.93(+27.3%) |
| 2019 | -12.51(-1.3%) |
| 2018 | -12.68 |
FAQ
- What is Y-mAbs Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Y-mAbs Therapeutics?
- What is YMAB EV/EBITDA year-to-date change?
- What is Y-mAbs Therapeutics EV/EBITDA year-on-year change?
What is Y-mAbs Therapeutics EV/EBITDA?
The current EV/EBITDA of YMAB is -7.35
What is the all time high EV/EBITDA for Y-mAbs Therapeutics?
Y-mAbs Therapeutics all-time high EV/EBITDA is -0.14
What is YMAB EV/EBITDA year-to-date change?
Y-mAbs Therapeutics EV/EBITDA has changed by +3.10 (+29.67%) since the beginning of the year
What is Y-mAbs Therapeutics EV/EBITDA year-on-year change?
Over the past year, YMAB EV/EBITDA has changed by +12.32 (+62.63%)